Baker Brothers Life Sciences LP
Director, 10% Owner · 4 filings · Latest: May 8, 2026
INCYTE CORP
Prelude Therapeutics Inc
Replimune Group, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
INCY | Baker Brothers Life Sciences LP | Director, 10% Owner | May 8, 2026 | Option Exercise | $84.53 | 30,000 | $2.5M | 28,203,718 | |
TARA | Baker Brothers Life Sciences, L.P. | — | Apr 23, 2026 | Proposed Sale | $5.35 | 300,176 | $1.6M | — | |
TARA | Baker Brothers Life Sciences, L.P. | — | Mar 6, 2026 | Proposed Sale | $5.85 | 461,723 | $2.7M | — | |
TARA | Baker Brothers Life Sciences, L.P. | — | Mar 4, 2026 | Proposed Sale | $6.26 | 424,125 | $2.7M | — | |
TARA | Baker Brothers Life Sciences, L.P. | — | Feb 25, 2026 | Proposed Sale | $5.81 | 947,479 | $5.5M | — | |
TARA | Baker Brothers Life Sciences, L.P. | — | Feb 24, 2026 | Proposed Sale | $6.04 | 322,039 | $1.9M | — | |
ONC | Baker Brothers Life Sciences, L.P. | — | Feb 28, 2025 | Proposed Sale | $260.00 | 671,976 | $174.7M | — | |
ONC | Baker Brothers Life Sciences, L.P. | — | Dec 9, 2024 | Proposed Sale | $187.27 | 950,907 | $178.1M | — |